TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
KZR

Kezar Life Sciences Inc

Healthcare · Biotechnology

0.175$ +6.1% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow KZR
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – –
– +13.6% +294.3% +88.6% +18.7% -2.2% -32.3% +4.2% -2.4% -206.3%
– +58.6% +881.8% +101.1% +23.4% +53.7% +84.4% +29.5% -28.3% -31.1%
– +58.6% +934.0% +90.9% +23.4% +53.7% +84.5% – – –
– – +106.7% +1,321.0% -328.3% – -463.7% – -127.6% –
– +194.7% +187.9% -45.8% -68.0% +62.9% +399.4% +14.7% -98.4% -72.4%
– +194.7% +21,469.2% – -376.7% -49.7% +221.3% – +5.8% +15.0%
– +138,108.3% +56.6% -99.7% +67.6% +357.0% -36.7% – – –
– – – +0.0% +0.0% +0.0% -100.0% – – –
– +138,108.3% +56.6% -99.7% +36,533.1% +13.0% +13.6% -99.5% -83.9% -10,376.7%
– – -165.1% – – +563.6% -153.8% – – +381.6%
– – – – – – – – – –

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?